Jaguar Health, Inc.
เพิ่มขึ้น

Heavy Volume in JAGX + Phase Trial Data Coming Soon

JAGX Showing Resistance At $0.50. Next Resistace Level is $0.61. A Move Upward Is Likely Due To The Stock Being Oversold and Phase Trial Data Expected Sometime Soon! Bullish.
Fundamental AnalysisSupport and ResistanceVolume

คำจำกัดสิทธิ์ความรับผิดชอบ